Dr Stefan Broselid, Founder and Scientific Lead of ECS Restore, has filed a patent application for a non-cannabinoid formulation designed to treat dysfunction in the endocannabinoid system (ECS), moving his research from scientific hypothesis towards a meaningful commercial proposition.
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium.
First published on Cannabis Health Medical cannabis patients made history in London with a first-of-its-kind, patient-led education event focused on cannabis-based medicines, hosted at the Charterhouse.
Sorting Evidence from Anecdote As global cannabis research accelerates, the number of published studies has never been higher, but not all evidence carries the same scientific weight.
Accredited Medical Cannabis Symposium Could ‘Benefit Thousands of Patients’, Says Expert
Today, Cannabis Europa 2025 welcomed hundreds of the world’s leading cannabis voices for its first jam packed day of sessions.
Despite being one of the most important regulatory systems in human physiology, the endocannabinoid system (ECS) remains inexplicably absent from almost all mainstream medical education.
